文献速递流行病学与生物统计

Meta流行病学综述发现系统评价纳入试验的发表文献中时间至事件分析的报告与处理存在差异

Meta-epidemiological review identified variable reporting and handling of time-to-event analyses in publications of trials included in meta-analyses of systematic reviews.
PubMed 文献 · J Clin Epidemiol · 2023-05-30

该Meta流行病学综述从Cochrane数据库和核心临床期刊中系统识别50篇系统评价,提取其中基于风险比(HR)的配对Meta分析所纳入的全部随机试验数据。共纳入235项试验的315项试验分析,发现总体生存率评估最多(91%),但结局定义(缺失61%)、删失原因(缺失41%)和随访说明(缺失56%)常报告不全。试验中可用的时间至事件数据最常见为生存曲线(83%)、对数秩P值(76%)和HR(72%)。

要点

  • 试验发表中时间至事件结局的定义、删失原因和随访说明常缺失,报告率分别为61%、41%和56%缺失。
  • 试验中可用的时间至事件数据以生存曲线(83%)、对数秩P值(76%)和HR(72%)最常见。
  • 除缺失结局数据外,信息性删失、治疗转换和比例风险等时间至事件相关试验特征在试验发表中偶有提及。

核心结论

  • 试验和综述发表中的时间至事件(Meta)分析需要明确的报告标准。
  • 试验发表中的报告局限性会传递到综述层面。

研究设计与样本

  • 从Cochrane数据库和核心临床期刊中系统识别50篇系统评价,提取其中基于风险比(HR)的配对Meta分析所纳入的全部随机试验数据。
  • 共纳入235项试验,对应315项试验分析。

主要发现

  • 评估最多的结局是总体生存率(91%)。
  • 试验结局的定义(61%)、删失原因(41%)和随访说明(56%)常缺失。
  • 每项试验可用的时间至事件数据最常见为生存曲线(83%)、对数秩P值(76%)和HR(72%)。
  • 当报告试验时间至事件数据重算时,综述多指定HR或P值(各5%)。
  • 综述主要纳入意向性治疗分析(64%)和未校正协变量的分析(25%)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Previous findings indicate limited reporting of systematic reviews with meta-analyses of time-to-event (TTE) outcomes. We assessed corresponding available information in trial publications included in such meta-analyses. STUDY DESIGN AND SETTING: We extracted data from all randomized trials in pairwise, hazard ratio (HR)-based meta-analyses of primary outcomes and overall survival of 50 systematic reviews systematically identified from the Cochrane Database and Core Clinical Journals. Data on methods and characteristics relevant for TTE analysis of reviews, trials, and outcomes were extracted. RESULTS: Meta-analyses included 235 trials with 315 trial analyses. Most prominently assessed was overall survival (91%). Definitions (61%), censoring reasons (41%), and follow-up specifications (56%) for trial outcomes were often missing. Available TTE data per trial were most frequently survival curves (83%), log-rank P values (76%), and HRs (72%). When trial TTE data recalculation was reported, reviews mostly specified HRs or P values (each 5%). Reviews primarily included intention-to-treat analyses (64%) and analyses not adjusted for covariates (25%). Except for missing outcome data, TTE-relevant trial characteristics, for example, informative censoring, treatment switching, and proportional hazards, were sporadically addressed in trial publications. Reporting limitations in trial publications translate to the review level. CONCLUSION: TTE (meta)-analyses, in trial and review publications, need clear reporting standards.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Goldkuhle M, Hirsch C, Iannizzi C, et al. Meta-epidemiological review identified variable reporting and handling of time-to-event analyses in publications of trials included in meta-analyses of systematic reviews. J Clin Epidemiol. 2023. PMID: 37263516. doi:10.1016/j.jclinepi.2023.05.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。